Maven Securities LTD Portage Biotech Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.57 - $12.0 $866,136 - $1.58 Million	-131,832 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.73 - $23.74 $996,945 - $2.21 Million	-92,912 Reduced 41.34%	131,832 $1.42 Million
Q3 2021 Nov 15, 2021	SELL	$13.65 - $22.4 $736,417 - $1.21 Million	-53,950 Reduced 19.36%	224,744 $4.57 Million
Q2 2021 Aug 16, 2021	BUY	$20.96 - $42.81 $5.84 Million - $11.9 Million	278,694 New	278,694 $6.33 Million

1.96M

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $117M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.